Recruiting A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors NCT07383506 Conditions Advanced Solid Tumors, Adult, Breast Diseases, Breast Neoplasms, +18 more Locations HonorHealth Research Institute — Scottsdale, Arizona, United States Washington University School of Medicine - Siteman Cancer Center — St Louis, Missouri, United States NEXT Austin — Austin, Texas, United States NEXT Virginia — Fairfax, Virginia, United States View Trial Details
